2. Sensitivity analysis for primary outcomes.
Study (number of participants) | OR (95% CI) Fixed‐effect | OR (95% CI) Random‐effects | RR (95% CI) Fixed‐effect | RR (95% CI) Random‐effects |
Cumulative live birth rate Chen 2016 (1508) Ferraretti 1999 (125) Santos‐Ribeiro 2020 (184) Shapiro 2011a (103) Shapiro 2011b (122) Vuong 2018 (782) Wei 2019 (1650) Wong 2021 (204) |
1.08 (0.95 to 1.22) | 1.08 (0.95 to 1.22) | 1.03 (0.98 to 1.07) | 1.03 (0.99 to 1.08) |
OHSS Chen 2016 (1508) Ferraretti 1999 (125) Santos‐Ribeiro 2020 (184) Vuong 2018 (782) Wei 2019 (1650) Wong 2021 (204) |
0.26 (0.17 to 0.39) | 0.25 (0.13 to 0.46) | 0.22 (0.14 to 0.37) | 0.25 (0.14 to 0.44) |
CI: confidence interval; OHSS: ovarian hyperstimulation syndrome; OR: odds ratio;RR: risk ratio |
In the studies of Santos‐Ribeiro 2020; Shapiro 2011a there was lost to follow up for the primary outcome and therefore numbers of participants differ with the Characteristics tables.